Catheter Precision Wins Two Patents for VIVO and Cardionomix
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
GALWAY, Ireland, May 10, 2026 WhiteSwell announced positive primary clinical results from the DELTA-HF feasibility trial evaluating its investigational...
MADRID & NEW YORK, January 29, 2026 — A multicenter randomized clinical trial has demonstrated that remote dielectric sensing...
